Medicare Enrolled
Dr. Barry Gruber, M.D.
Rheumatology · Babylon, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gruber from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gruber?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gruber
Dr. Barry Gruber is a rheumatology specialist in Babylon, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gruber performed 300,657 Medicare services across 3,997 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gruber received a total of $853,539 from 63 pharmaceutical and/or device companies across 2112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gruber is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NY
$853,539 industry payments
Medicare Practice Summary
Medicare Utilization ↗300,657
Medicare services
Top 0% in NY for rheumatology
3,997
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15,033 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 76,860 | $8 | $14 |
| Tocilizumab injection (Actemra) | 71,721 | $5 | $10 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
71,600 | $4 | $25 |
| Denosumab injection (Prolia/Xgeva) | 58,920 | $18 | $55 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
12,375 | $34 | $126 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
2,528 | $13 | $62 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,666 | $13 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,610 | $106 | $300 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
461 | $1 | $8 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
373 | $45 | $350 |
| 5% dextrose/water (500 ml = 1 unit) | 372 | $1 | $15 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
369 | $1 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
217 | $126 | $400 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
202 | $62 | $175 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
191 | $62 | $350 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
166 | $70 | $200 |
| X-ray of thigh bone, 1 view An X-ray image of the thigh bone (femur) taken from a single angle to visualize the bone structure. |
164 | $25 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
164 | $146 | $400 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
162 | $91 | $450 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
114 | $27 | $150 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
96 | $6 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $65 | $200 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
50 | $15 | $75 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
48 | $52 | $400 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
41 | $36 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
39 | $72 | $80 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
28 | $51 | $200 |
| Injection of carpal tunnel | 19 | $76 | $200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $86 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
94.6% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$853,539
Total received (2018-2024)
Avg $121,934/year across 7 years
Top 1% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
2,112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$745,765 (87.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$92,495 (10.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,279 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$72,908
2023
$83,152
2022
$71,051
2021
$77,488
2020
$80,349
2019
$245,006
2018
$223,585
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$49,230
ABBVIE INC.
$12,390
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,543
UCB, Inc.
$522
Janssen Biotech, Inc.
$446
Aurinia Pharma U.S., Inc.
$234
Lilly USA, LLC
$218
Kyowa Kirin, Inc.
$216
AstraZeneca Pharmaceuticals LP
$125
Janssen Scientific Affairs, LLC
$114
Novartis Pharmaceuticals Corporation
$105
GlaxoSmithKline, LLC.
$102
ANI Pharmaceuticals, Inc.
$101
Organon Llc
$91
Kiniksa Pharmaceuticals International, plc
$77
PFIZER INC.
$62
Actelion Pharmaceuticals US, Inc.
$55
Radius Health, Inc.
$55
Alexion Pharmaceuticals, Inc.
$51
Zimmer Biomet Holdings, Inc.
$43
Mallinckrodt Hospital Products Inc.
$31
DePuy Synthes Sales Inc.
$25
Ferring Pharmaceuticals Inc.
$20
Teva Pharmaceuticals USA, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$19
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 96.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$406,951
Radius Health, Inc.
$81,747
Horizon Therapeutics plc
$56,029
Boehringer Ingelheim Pharmaceuticals, Inc.
$39,512
United Rheumatology
$36,298
Horizon Pharma plc
$36,284
E.R. Squibb & Sons, L.L.C.
$35,959
Regeneron Healthcare Solutions, Inc.
$26,307
Celgene Corporation
$25,809
Flexion Therapeutics, Inc.
$19,003
Pacira Therapeutics, Inc.
$16,225
GENZYME CORPORATION
$15,931
ABBVIE INC.
$14,329
Mallinckrodt Enterprises LLC
$10,483
Mallinckrodt LLC
$8,760
Janssen Scientific Affairs, LLC
$5,697
Janssen Biotech, Inc.
$4,481
Mallinckrodt Hospital Products Inc.
$1,886
Fresenius Kabi USA, LLC
$1,638
UCB, Inc.
$1,339
PFIZER INC.
$1,222
Lilly USA, LLC
$828
Aurinia Pharma U.S., Inc.
$794
Novartis Pharmaceuticals Corporation
$715
Genentech USA, Inc.
$694
AbbVie, Inc.
$687
GlaxoSmithKline, LLC.
$520
Biohaven Pharmaceutical Holding Company Ltd.
$319
AstraZeneca Pharmaceuticals LP
$310
Antares Pharma, Inc.
$250
AbbVie Inc.
$218
Kyowa Kirin, Inc.
$216
Ferring Pharmaceuticals Inc.
$170
Actelion Pharmaceuticals US, Inc.
$164
ANI Pharmaceuticals, Inc.
$156
Merck Sharp & Dohme Corporation
$148
MEDEXUS PHARMA, INC.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$131
MEDAC PHARMA, INC.
$130
Alexion Pharmaceuticals, Inc.
$123
Organon Llc
$91
Zimmer Biomet Holdings, Inc.
$85
Kiniksa Pharmaceuticals International, plc
$77
DePuy Synthes Sales Inc.
$75
West-Ward Pharmaceuticals
$71
Hikma Pharmaceuticals USA
$65
Ultragenyx Pharmaceutical Inc.
$55
Organon LLC
$54
Sobi, Inc
$53
Exeltis, USA Inc.
$45
Intercept Pharmaceuticals, Inc.
$41
Pacira Pharmaceuticals Incorporated
$31
BioXcel Therapeutics, Inc.
$28
Bioventus LLC
$26
Teva Pharmaceuticals USA, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$19
Egalet US Inc
$18
Kowa Pharmaceuticals America, Inc.
$16
Abbott Laboratories
$15
Shire North American Group Inc
$13
Sandoz Inc.
$13
Ironwood Pharmaceuticals, Inc
$11
Sebela Pharmaceuticals Inc.
$11
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · AccuFill · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · CRYSViTA · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · IGALMI · ILARIS · INFLECTRA · Iovera · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NURTEC ODT · OCALIVA · OFEV · OMVOH · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · UPTRAVI · Uloric · VIMOVO · VISCO-3 sodium hyaluronate · XELJANZ · XYOSTED · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for rheumatology in NY.
Geographic Context
Rheumatologists within 10 mi
94
Per 100K population
6.2
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gruber is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gruber experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Gruber performed 76,860 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gruber receive payments from pharmaceutical companies?
Yes. Dr. Gruber received a total of $853,539 from 63 companies across 2,112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gruber's costs compare to other rheumatologists in Babylon?
Dr. Gruber's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gruber) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Babylon
Browse rheumatologists in Babylon ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Radius Health, Inc. Payments to Doctors
See all physicians who received payments from Radius Health, Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology